We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

178 hedge funds and large institutions have $2.69B invested in Agios Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 66 increasing their positions, 58 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 22

14% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 58

4% more funds holding

Funds holding: 171 → 178 (+7)

1.21% more ownership

Funds ownership: 95.18% → 96.38% (+1.2%)

13% less capital invested

Capital invested by funds: $3.07B → $2.69B (-$388M)

33% less call options, than puts

Call options by funds: $10.2M | Put options by funds: $15.1M

80% less funds holding in top 10

Funds holding in top 10: 5 → 1 (-4)

Holders
178
Holders Change
+7
Holders Change %
+4.09%
% of All Funds
4.04%
Holding in Top 10
1
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-80%
% of All Funds
0.02%
New
30
Increased
66
Reduced
58
Closed
22
Calls
$10.2M
Puts
$15.1M
Net Calls
-$4.96M
Net Calls Change
-$9.09M

Top Buyers

1
UBS AM
UBS AM
Illinois
+$19.7M
2
PAMU
Pictet Asset Management (UK)
United Kingdom
+$14.7M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$14M
4
PI
Putnam Investments
Massachusetts
+$13.3M
5
First Trust Advisors
First Trust Advisors
Illinois
+$10.7M

Top Sellers

1
Capital International Investors
Capital International Investors
California
-$20.5M
2
CI
Capital International
California
-$13.2M
3
QIM
Quantitative Investment Management
Virginia
-$10.3M
4
Invesco
Invesco
Georgia
-$8.69M
5
CWAM
Columbia Wanger Asset Management
Illinois
-$8.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Squarepoint
101
Squarepoint
New York
$977K +$813K +12,927 +311%
Neuberger Berman Group
102
Neuberger Berman Group
New York
$927K +$1.02M +16,210 New
Jacobs Levy Equity Management
103
Jacobs Levy Equity Management
New Jersey
$886K +$975K +15,500 New
PA
104
Profund Advisors
Maryland
$870K -$123K -1,956 -11%
VOYA Investment Management
105
VOYA Investment Management
Georgia
$851K -$42.2K -671 -4%
SIM
106
Spark Investment Management
New York
$834K -$2.18M -34,600 -70%
Teacher Retirement System of Texas
107
Teacher Retirement System of Texas
Texas
$802K +$671K +10,657 +316%
Principal Financial Group
108
Principal Financial Group
Iowa
$764K +$483K +7,679 +135%
Allianz Asset Management
109
Allianz Asset Management
Germany
$694K – – –
WMSA
110
Weiss Multi-Strategy Advisers
New York
$686K +$126K +2,000 +20%
Asset Management One
111
Asset Management One
Japan
$659K -$2.34M -37,248 -77%
BAM
112
Belpointe Asset Management
Nevada
$657K -$455K -7,231 -39%
BNP Paribas Financial Markets
113
BNP Paribas Financial Markets
France
$576K -$135K -2,138 -18%
Federated Hermes
114
Federated Hermes
Pennsylvania
$520K -$1.18M -18,783 -67%
Bank of America
115
Bank of America
North Carolina
$498K -$824K -13,094 -60%
State of Wisconsin Investment Board
116
State of Wisconsin Investment Board
Wisconsin
$489K +$6.92K +110 +1%
N
117
Nuveen
North Carolina
$489K +$538K +8,550 New
BPGAM
118
BTG Pactual Global Asset Management
Bermuda
$475K +$17.7K +281 +4%
AB
119
Amalgamated Bank
New York
$474K +$28.9K +460 +6%
URS
120
Utah Retirement Systems
Utah
$440K +$6.29K +100 +1%
WAM
121
Weiss Asset Management
Massachusetts
$427K +$281K +4,465 +149%
Citigroup
122
Citigroup
New York
$422K +$270K +4,296 +139%
Simplex Trading
123
Simplex Trading
Illinois
$399K +$438K +6,957 +18,803%
FIM
124
Foresters Investment Management
New York
$398K -$133K -2,120 -23%
Public Employees Retirement Association of Colorado
125
Public Employees Retirement Association of Colorado
Colorado
$387K +$16.6K +264 +4%
3 4
5
6 7

AGIO Hedge Fund Activity: Q4 2017 in Review

178 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q4 2017, worth a combined $2.69B — down 13% from $3.07B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new AGIO positions and 22 closed out — a net gain of 8 holders — while 66 added to existing stakes and 58 trimmed.

The largest buyer was UBS AM, adding an estimated $19.7M. The largest seller was Capital International Investors, cutting an estimated $20.5M.

  • 178 institutional investors held Agios Pharmaceuticals (AGIO) as of Q4 2017, up from 171 in Q3 2017.
  • Funds reported $2.69B of Agios Pharmaceuticals stock for Q4 2017, down 13% quarter-over-quarter.
  • 30 funds opened new Agios Pharmaceuticals positions in Q4 2017 and 22 closed out, a net change of +8 holders.
  • The largest Agios Pharmaceuticals buyer in Q4 2017 was UBS AM, an estimated $19.7M added.
  • The largest Agios Pharmaceuticals seller in Q4 2017 was Capital International Investors, an estimated $20.5M sold.

Based on aggregated 13F filings for Q4 2017.